| CRISPR-based tools: Alternative methods for the diagnosis of COVID-19 F Palaz, AK Kalkan, A Tozluyurt, M Ozsoz Clinical biochemistry 89, 1-13, 2021 | 80 | 2021 |
| CRISPR-Cas13 system as a promising and versatile tool for cancer diagnosis, therapy, and research F Palaz, AK Kalkan, O Can, AN Demir, A Tozluyurt, A Ozcan, M Ozsoz ACS Synthetic Biology 10 (6), 1245-1267, 2021 | 53 | 2021 |
| RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection Methods K Selvam, MA Najib, MF Khalid, S Mohamad, F Palaz, M Ozsoz, I Aziah Diagnostics 11 (9), 1646, 2021 | 32 | 2021 |
| A highly potent SARS-CoV-2 blocking lectin protein RE Ahan, A Hanifehnezhad, ES Kehribar, TC Oguzoglu, K Foldes, ... ACS Infectious Diseases 8 (7), 1253-1264, 2022 | 25 | 2022 |
| Detection of CRISPR-Cas9-mediated mutations using a carbon nanotube-modified electrochemical genosensor E Kivrak, T Pauzaite, NA Copeland, JG Hardy, P Kara, M Firlak, ... Biosensors 11 (1), 17, 2021 | 8 | 2021 |
| Improving recombinant protein production in CHO cells using the CRISPR-Cas system AK Kalkan, F Palaz, S Sofija, N Elmousa, Y Ledezma, E Cachat, ... Biotechnology Advances 64, 108115, 2023 | 5 | 2023 |
| Applications of CRISPR Epigenome Editors in Tumor Immunology and Autoimmunity B Yahsi, F Palaz, P Dincer ACS Synthetic Biology, 2024 | 3 | 2024 |
| Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy F Palaz The New England Journal of Medicine 389 (23), 2210-2211, 2023 | 1 | 2023 |
| CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma F Palaz, M Ozsoz, A Zarrinpar, I Sahin Journal of Hepatocellular Carcinoma, 975-995, 2024 | | 2024 |
| Assessing the potential of DZIP1L gene in autosomal recessive polycystic kidney disease gene therapy F Palaz Pediatric Discovery 2 (1), e44, 2023 | | 2023 |
| Clinical Validation and Evaluation of a Colorimetric SARS-CoV-2 RT-LAMP Assay Against RT-PCR M Erdem, A Andac, A Özketen, G Karahan, A Tozluyurt, F Palaz, A Alp, ... Infectious Diseases and Clinical Microbiology 5 (2), 136–143, 2023 | | 2023 |
